Our in vivo differential gene expression analysis revealed a downregulation of the gene IDO1 which codes for a tumor-promoting enzyme [70] and the gene for the metastasis-promoting cytokine IL6 was also downregulated. The gene discussed is IDO1; the disease is neoplasm.